drugset / Trial / NCT04419025
Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the efficacy of N-acetylcysteine (NAC) in preventing those with mild or moderate COVID-19 from progressing to severe disease
Timeline
- Start
- 2020-09-23
- Primary completion
- 2021-05-14
- Completion
- 2021-05-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | N-acetylcysteine | Small molecule | 25 mg/kg | Oral |
| Comparator | N-acetylcysteine | Small molecule | 1200 mg | Oral |